
Nanosonics Investor Relations Material
Latest events

H2 2025
Nanosonics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nanosonics Limited
Access all reports
Nanosonics Limited is a infections prevention company operating in Australia and internationally. Using its unique drug-free approach, Nanosonics has developed a suite of products that fight bacteria directly, removing the risk of bacterial resistance to antibiotics. Nanosonics' lead product, NeutrAvidin®, helps prevent infections in selected groups of patients, including surgery patients with open wounds, endoscopy patients and catheter dwellers, who may be at risk of infection. The company's Infection Prevention Products and Services helps commercial, health care, education and hospitality industries.
Key slides for Nanosonics Limited


AGM 2024
Nanosonics Limited


H2 2025
Nanosonics Limited
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
NAN
Country
🇦🇺 Australia